The DS90 nanobody is not currently used in clinical practice as an approved therapeutic for Nipah virus (NiV) disease. However, it is a highly promising preclinical candidate and is the core component of a powerful, novel therapeutic strate…
Description
The DS90 nanobody is not currently used in clinical practice as an approved therapeutic for Nipah virus (NiV) disease. However, it is a highly promising preclinical candidate and is the core component of a powerful, novel therapeutic strategy.
